Annual CFF
$9.08 M
+$9.08 M+100.00%
December 1, 2024
Summary
- As of March 11, 2025, VRPX annual cash flow from financing activities is $9.08 million, with the most recent change of +$9.08 million (+100.00%) on December 1, 2024.
- During the last 3 years, VRPX annual CFF has fallen by -$42.25 million (-82.30%).
- VRPX annual CFF is now -82.30% below its all-time high of $51.33 million, reached on December 31, 2021.
Performance
VRPX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.37 M
+$1.75 M+66.93%
December 1, 2024
Summary
- As of March 11, 2025, VRPX quarterly cash flow from financing activities is $4.37 million, with the most recent change of +$1.75 million (+66.93%) on December 1, 2024.
- Over the past year, VRPX quarterly CFF has stayed the same.
- VRPX quarterly CFF is now -87.87% below its all-time high of $35.99 million, reached on September 30, 2021.
Performance
VRPX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$9.08 M
+$4.37 M+92.55%
December 1, 2024
Summary
- As of March 11, 2025, VRPX TTM cash flow from financing activities is $9.08 million, with the most recent change of +$4.37 million (+92.55%) on December 1, 2024.
- Over the past year, VRPX TTM CFF has stayed the same.
- VRPX TTM CFF is now -82.30% below its all-time high of $51.33 million, reached on December 31, 2021.
Performance
VRPX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VRPX Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.0% | 0.0% | 0.0% |
| 3 y3 years | -82.3% | +8478.6% | -82.3% |
| 5 y5 years | +707.5% | -87.9% | -82.3% |
VRPX Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.3% | -100.0% | at high | -100.0% | -82.3% | -100.0% |
| 5 y | 5-year | -82.3% | -100.0% | -87.9% | +8678.6% | -82.3% | -100.0% |
| alltime | all time | -82.3% | -100.0% | -87.9% | +8678.6% | -82.3% | -100.0% |
Virpax Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $9.08 M(>+9900.0%) | $4.37 M(+66.9%) | $9.08 M(+92.5%) |
| Sep 2024 | - | $2.62 M(+58.7%) | $4.72 M(+124.4%) |
| Jun 2024 | - | $1.65 M(+263.0%) | $2.10 M(+363.0%) |
| Mar 2024 | - | $454.00 K(>+9900.0%) | $454.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2021 | $51.33 M | $50.90 K(-99.9%) | $51.33 M(+0.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $35.99 M(>+9900.0%) | $51.23 M(+225.8%) |
| Jun 2021 | - | $0.00(-100.0%) | $15.72 M(-3.3%) |
| Mar 2021 | - | $15.29 M(<-9900.0%) | $16.26 M(+1063.2%) |
| Dec 2020 | $1.40 M(+24.3%) | -$50.90 K(-110.5%) | $1.40 M(-3.5%) |
| Sep 2020 | - | $483.00 K(-10.7%) | $1.45 M(+50.0%) |
| Jun 2020 | - | $541.00 K(+27.3%) | $966.00 K(+127.3%) |
| Mar 2020 | - | $425.00 K | $425.00 K |
| Dec 2019 | $1.13 M(-32.8%) | - | - |
| Dec 2018 | $1.67 M | - | - |
FAQ
- What is Virpax Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual CFF year-on-year change?
- What is Virpax Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly CFF year-on-year change?
- What is Virpax Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals TTM CFF year-on-year change?
What is Virpax Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of VRPX is $9.08 M
What is the all time high annual CFF for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual cash flow from financing activities is $51.33 M
What is Virpax Pharmaceuticals annual CFF year-on-year change?
Over the past year, VRPX annual cash flow from financing activities has changed by +$9.08 M (+100.00%)
What is Virpax Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of VRPX is $4.37 M
What is the all time high quarterly CFF for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly cash flow from financing activities is $35.99 M
What is Virpax Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, VRPX quarterly cash flow from financing activities has changed by $0.00 (0.00%)
What is Virpax Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of VRPX is $9.08 M
What is the all time high TTM CFF for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high TTM cash flow from financing activities is $51.33 M
What is Virpax Pharmaceuticals TTM CFF year-on-year change?
Over the past year, VRPX TTM cash flow from financing activities has changed by $0.00 (0.00%)